How does IDEX (IEX) make money?

IDEX (IEX) generates revenue primarily from Health And Science Technologies, which accounted for 44.6% of total revenue in TTM through Q2 2026. The company reported $3.59B in revenue and converted 14.5% of it into net profit, equivalent to roughly $520M in net income — what's left after the cost of revenue, operating expenses, interest, and income taxes.

What is the gross profit margin of IDEX (IEX)?

IDEX (IEX) reported a gross profit margin of 44.7% in TTM through Q2 2026, equivalent to $1.6B in gross profit on $3.59B in revenue. Gross margin measures how much of each dollar of revenue remains after the direct cost of producing or delivering the product — a higher figure typically signals pricing power, scale, or a less capital-intensive business model.

What is the operating profit margin of IDEX (IEX)?

IDEX (IEX) reported an operating profit margin of 20.8% in TTM through Q2 2026, equivalent to $744M in operating income. Operating margin captures profitability after research & development, sales & marketing, and general & administrative expenses — but before interest, taxes, and one-off items — and is the cleanest single read on the underlying business's efficiency.

What is the net profit margin of IDEX (IEX)?

IDEX (IEX) reported a net profit margin of 14.5% in TTM through Q2 2026, equivalent to $520M in net income. Net margin is the bottom-line share of revenue that survives every expense — operating costs, interest, and income taxes — and is the figure that flows directly into earnings per share.

Is IDEX (IEX) profitable?

Yes. IDEX (IEX) reported $520M in net income for TTM through Q2 2026, with a net profit margin of 14.5%. The company earned more from its operations than it paid out in costs, interest, and income taxes, leaving positive earnings on the bottom line.

How much does IDEX (IEX) spend on capital expenditures?

IDEX (IEX) spent $75.2M on capital expenditures (CapEx) during TTM through Q2 2026, roughly 2.1% of total revenue. CapEx represents long-lived investment in property, equipment, data centres, and other physical infrastructure, and is subtracted from operating cash flow to arrive at free cash flow.

How much free cash flow does IDEX (IEX) generate?

IDEX (IEX) generated $642M in free cash flow during TTM through Q2 2026, a free-cash-flow margin of 17.9%. Free cash flow is the cash left after capital expenditures and represents the discretionary pool the company can use to pay dividends, repurchase shares, repay debt, or fund acquisitions without raising external capital.

What is the effective tax rate of IDEX (IEX)?

IDEX (IEX) had an effective tax rate of 23.8% in TTM through Q2 2026. The effective rate is the actual share of pre-tax income paid as income taxes and can differ materially from the statutory rate due to foreign earnings mix, tax credits (such as R&D), share-based compensation deductions, and one-off discrete items.

What are the main business segments of IDEX (IEX)?

IDEX (IEX) reports revenue across 3 reportable product segments, led by Health And Science Technologies at 44.6% of total revenue in TTM through Q2 2026. See the revenue-by-segment table on this page for the full breakdown and how each segment feeds into the income-statement waterfall above.

Where does IDEX (IEX) generate most of its revenue?

UNITED STATES is the largest geographic market for IDEX (IEX), accounting for 45.8% of revenue in the most recent annual filing. The complete regional split — including international markets and any Rest-of-World rollup — is shown in the revenue-by-geography table on this page.

How IDEX Makes Money: 2026 Visual Revenue Map

IDEX (IEX) Income Statement Flow — TTM through Q2 2026

Calculated from the four most recent reported quarters, ending June 30, 2026 (reported July 29, 2026).

IDEX (IEX) Revenue by Product Segment — TTM through Q2 2026

Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported segments changed mid-year.

Revenue contribution by product segment for IDEX (IEX), TTM through Q2 2026.
Segment	Revenue (USD)	% of total
Health And Science Technologies	$1.6B	44.6%
Fluid And Metering Technologies	$1.24B	34.6%
Fire And Safety Diversified Products	$746M	20.8%
Total	$3.59B	100%

Health And Science Technologies$1.6B
Fluid And Metering Technologies$1.24B
Fire And Safety Diversified Products$746M
Total$3.59B

IDEX (IEX) Revenue by Geography — TTM through Q2 2026

Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported regions changed mid-year.

Revenue contribution by geographic region for IDEX (IEX), TTM through Q2 2026
Region	Revenue (USD)	% of total
UNITED STATES	$1.34B	45.8%
Europe	$880M	30.1%
Asia	$577M	19.7%
North America, Excluding United States	$130M	4.4%
Total	$2.93B	100%

UNITED STATES
Europe
Asia
North America, Excluding United States
Total

Revenue Breakdown — TTM through Q2 2026

In TTM through Q2 2026, IDEX (IEX) reports revenue across 3 reportable product segments; the largest segment was Health And Science Technologies at 44.6%, followed by Fluid And Metering Technologies (34.6%) and Fire And Safety Diversified Products (20.8%). Geographically, UNITED STATES accounted for 45.8% of revenue, followed by Europe (30.1%) and Asia (19.7%).

Frequently asked questions

Data & methodology

IDEX (IEX) Key Financials

Charts, filings, and peer comparison for every metric

Trains Company Knowledge

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

IEX Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation